Abiopharma

News list

Wang Wenbei 🟡 adjusted position in 0 shares (1 derivative) of Kanzhun Ltd (BZ) Transaction Date: Jun 16, 2026 | Filing ID: 075118

Full text

News bot June 17, 2026, 8:02 p.m.
🔍 Wang Wenbei (Executive)

Company: Kanzhun Ltd (BZ)

Report Date: 2026-06-16
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 25,000
- Total shares sold: 25,000
Detailed Transactions and Holdings:
- Acquired 25,000 shares of Class A ordinary shares (Direct)
  Date: 2026-06-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 148,588.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
- Sold 25,000 shares of Restricted Share Unit (Derivative)
  Date: 2026-06-16 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F4, F4
Footnotes:
- F1: These Class A ordinary shares are held through American Depositary Shares ("ADS") of the issuer. Each ADS represents two Class A ordinary shares.
- F2: Represents Class A ordinary shares acquired in the form of ADS upon the vesting of restricted share units ("RSU") on June 16, 2026.
- F3: Each RSU represents a contingent right to receive one Class A ordinary share at settlement.
- F4: The RSUs vested on June 16, 2026.